nodes	percent_of_prediction	percent_of_DWPC	metapath
Reserpine—Voacamine—Vincristine—lymphatic system cancer	0.553	1	CrCrCtD
Reserpine—SLC22A2—Cytarabine—lymphatic system cancer	0.0991	0.238	CbGbCtD
Reserpine—SLC22A1—Cytarabine—lymphatic system cancer	0.0861	0.206	CbGbCtD
Reserpine—ABCB11—Vincristine—lymphatic system cancer	0.073	0.175	CbGbCtD
Reserpine—CYP3A5—Teniposide—lymphatic system cancer	0.0399	0.0957	CbGbCtD
Reserpine—ABCC2—Vincristine—lymphatic system cancer	0.0384	0.092	CbGbCtD
Reserpine—ABCC2—Methotrexate—lymphatic system cancer	0.0232	0.0557	CbGbCtD
Reserpine—CYP3A5—Vincristine—lymphatic system cancer	0.0192	0.0461	CbGbCtD
Reserpine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0182	0.0436	CbGbCtD
Reserpine—ABCB1—Vincristine—lymphatic system cancer	0.0125	0.03	CbGbCtD
Reserpine—ABCB1—Methotrexate—lymphatic system cancer	0.00757	0.0182	CbGbCtD
Reserpine—Optic atrophy—Vincristine—lymphatic system cancer	0.00311	0.104	CcSEcCtD
Reserpine—Deafness—Fludarabine—lymphatic system cancer	0.000793	0.0264	CcSEcCtD
Reserpine—Angina pectoris—Fludarabine—lymphatic system cancer	0.000597	0.0199	CcSEcCtD
Reserpine—Dysuria—Fludarabine—lymphatic system cancer	0.000573	0.0191	CcSEcCtD
Reserpine—Gynaecomastia—Carmustine—lymphatic system cancer	0.000559	0.0186	CcSEcCtD
Reserpine—Epistaxis—Fludarabine—lymphatic system cancer	0.000515	0.0172	CcSEcCtD
Reserpine—Anorexia—Mechlorethamine—lymphatic system cancer	0.000513	0.0171	CcSEcCtD
Reserpine—Arrhythmia—Teniposide—lymphatic system cancer	0.000499	0.0166	CcSEcCtD
Reserpine—Deafness—Vincristine—lymphatic system cancer	0.000484	0.0161	CcSEcCtD
Reserpine—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.000468	0.0156	CcSEcCtD
Reserpine—Arrhythmia—Fludarabine—lymphatic system cancer	0.000438	0.0146	CcSEcCtD
Reserpine—Oedema—Teniposide—lymphatic system cancer	0.000397	0.0132	CcSEcCtD
Reserpine—Pruritus—Mechlorethamine—lymphatic system cancer	0.000381	0.0127	CcSEcCtD
Reserpine—Anorexia—Teniposide—lymphatic system cancer	0.000378	0.0126	CcSEcCtD
Reserpine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000368	0.0123	CcSEcCtD
Reserpine—Dyspnoea—Teniposide—lymphatic system cancer	0.000354	0.0118	CcSEcCtD
Reserpine—Dysuria—Vincristine—lymphatic system cancer	0.00035	0.0117	CcSEcCtD
Reserpine—Oedema—Fludarabine—lymphatic system cancer	0.000348	0.0116	CcSEcCtD
Reserpine—Erectile dysfunction—Vincristine—lymphatic system cancer	0.000345	0.0115	CcSEcCtD
Reserpine—Decreased appetite—Teniposide—lymphatic system cancer	0.000345	0.0115	CcSEcCtD
Reserpine—Vomiting—Mechlorethamine—lymphatic system cancer	0.000342	0.0114	CcSEcCtD
Reserpine—Rash—Mechlorethamine—lymphatic system cancer	0.000339	0.0113	CcSEcCtD
Reserpine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000339	0.0113	CcSEcCtD
Reserpine—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.000336	0.0112	CcSEcCtD
Reserpine—Anorexia—Fludarabine—lymphatic system cancer	0.000332	0.0111	CcSEcCtD
Reserpine—Weight increased—Mitoxantrone—lymphatic system cancer	0.000332	0.0111	CcSEcCtD
Reserpine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.000325	0.0108	CcSEcCtD
Reserpine—Nausea—Mechlorethamine—lymphatic system cancer	0.000319	0.0107	CcSEcCtD
Reserpine—Dyspnoea—Fludarabine—lymphatic system cancer	0.000311	0.0104	CcSEcCtD
Reserpine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000303	0.0101	CcSEcCtD
Reserpine—Pain—Fludarabine—lymphatic system cancer	0.000298	0.00993	CcSEcCtD
Reserpine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000297	0.00991	CcSEcCtD
Reserpine—Pruritus—Teniposide—lymphatic system cancer	0.000281	0.00935	CcSEcCtD
Reserpine—Arrhythmia—Carmustine—lymphatic system cancer	0.00028	0.00935	CcSEcCtD
Reserpine—Diarrhoea—Teniposide—lymphatic system cancer	0.000271	0.00904	CcSEcCtD
Reserpine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000261	0.00869	CcSEcCtD
Reserpine—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000259	0.00864	CcSEcCtD
Reserpine—Oedema—Bleomycin—lymphatic system cancer	0.000256	0.00852	CcSEcCtD
Reserpine—Vomiting—Teniposide—lymphatic system cancer	0.000252	0.0084	CcSEcCtD
Reserpine—Rash—Teniposide—lymphatic system cancer	0.00025	0.00833	CcSEcCtD
Reserpine—Dermatitis—Teniposide—lymphatic system cancer	0.00025	0.00833	CcSEcCtD
Reserpine—Headache—Teniposide—lymphatic system cancer	0.000248	0.00828	CcSEcCtD
Reserpine—Pruritus—Fludarabine—lymphatic system cancer	0.000247	0.00822	CcSEcCtD
Reserpine—Anorexia—Bleomycin—lymphatic system cancer	0.000244	0.00812	CcSEcCtD
Reserpine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000238	0.00795	CcSEcCtD
Reserpine—Nausea—Teniposide—lymphatic system cancer	0.000236	0.00785	CcSEcCtD
Reserpine—Anxiety—Carmustine—lymphatic system cancer	0.000232	0.00773	CcSEcCtD
Reserpine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000228	0.00759	CcSEcCtD
Reserpine—Oedema—Carmustine—lymphatic system cancer	0.000223	0.00744	CcSEcCtD
Reserpine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000222	0.0074	CcSEcCtD
Reserpine—Vomiting—Fludarabine—lymphatic system cancer	0.000222	0.00739	CcSEcCtD
Reserpine—Rash—Fludarabine—lymphatic system cancer	0.00022	0.00733	CcSEcCtD
Reserpine—Dermatitis—Fludarabine—lymphatic system cancer	0.00022	0.00732	CcSEcCtD
Reserpine—Pain—Bleomycin—lymphatic system cancer	0.000218	0.00728	CcSEcCtD
Reserpine—Headache—Fludarabine—lymphatic system cancer	0.000218	0.00728	CcSEcCtD
Reserpine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000216	0.00719	CcSEcCtD
Reserpine—Oedema—Vincristine—lymphatic system cancer	0.000213	0.0071	CcSEcCtD
Reserpine—Anorexia—Carmustine—lymphatic system cancer	0.000213	0.00709	CcSEcCtD
Reserpine—Oedema—Mitoxantrone—lymphatic system cancer	0.000207	0.00691	CcSEcCtD
Reserpine—Nausea—Fludarabine—lymphatic system cancer	0.000207	0.0069	CcSEcCtD
Reserpine—Shock—Mitoxantrone—lymphatic system cancer	0.000204	0.0068	CcSEcCtD
Reserpine—Anorexia—Vincristine—lymphatic system cancer	0.000203	0.00677	CcSEcCtD
Reserpine—Dyspnoea—Carmustine—lymphatic system cancer	0.000199	0.00663	CcSEcCtD
Reserpine—Somnolence—Carmustine—lymphatic system cancer	0.000198	0.00661	CcSEcCtD
Reserpine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000198	0.00659	CcSEcCtD
Reserpine—Decreased appetite—Carmustine—lymphatic system cancer	0.000194	0.00646	CcSEcCtD
Reserpine—Pain—Carmustine—lymphatic system cancer	0.000191	0.00636	CcSEcCtD
Reserpine—Decreased appetite—Vincristine—lymphatic system cancer	0.000185	0.00617	CcSEcCtD
Reserpine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000185	0.00616	CcSEcCtD
Reserpine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000184	0.00615	CcSEcCtD
Reserpine—Pain—Vincristine—lymphatic system cancer	0.000182	0.00607	CcSEcCtD
Reserpine—Pruritus—Bleomycin—lymphatic system cancer	0.000181	0.00603	CcSEcCtD
Reserpine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00018	0.00601	CcSEcCtD
Reserpine—Pain—Mitoxantrone—lymphatic system cancer	0.000177	0.00591	CcSEcCtD
Reserpine—Dysuria—Methotrexate—lymphatic system cancer	0.00017	0.00566	CcSEcCtD
Reserpine—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000167	0.00558	CcSEcCtD
Reserpine—Vomiting—Bleomycin—lymphatic system cancer	0.000162	0.00542	CcSEcCtD
Reserpine—Drowsiness—Methotrexate—lymphatic system cancer	0.000162	0.0054	CcSEcCtD
Reserpine—Rash—Bleomycin—lymphatic system cancer	0.000161	0.00537	CcSEcCtD
Reserpine—Dermatitis—Bleomycin—lymphatic system cancer	0.000161	0.00537	CcSEcCtD
Reserpine—Epistaxis—Methotrexate—lymphatic system cancer	0.000153	0.00509	CcSEcCtD
Reserpine—Diarrhoea—Carmustine—lymphatic system cancer	0.000153	0.00509	CcSEcCtD
Reserpine—Nausea—Bleomycin—lymphatic system cancer	0.000152	0.00506	CcSEcCtD
Reserpine—Dizziness—Carmustine—lymphatic system cancer	0.000147	0.00492	CcSEcCtD
Reserpine—Diarrhoea—Vincristine—lymphatic system cancer	0.000146	0.00486	CcSEcCtD
Reserpine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000142	0.00473	CcSEcCtD
Reserpine—Vomiting—Carmustine—lymphatic system cancer	0.000142	0.00473	CcSEcCtD
Reserpine—Dizziness—Vincristine—lymphatic system cancer	0.000141	0.00469	CcSEcCtD
Reserpine—Rash—Carmustine—lymphatic system cancer	0.000141	0.00469	CcSEcCtD
Reserpine—Dermatitis—Carmustine—lymphatic system cancer	0.00014	0.00468	CcSEcCtD
Reserpine—Headache—Carmustine—lymphatic system cancer	0.00014	0.00466	CcSEcCtD
Reserpine—Vomiting—Vincristine—lymphatic system cancer	0.000135	0.00451	CcSEcCtD
Reserpine—Rash—Vincristine—lymphatic system cancer	0.000134	0.00448	CcSEcCtD
Reserpine—Dermatitis—Vincristine—lymphatic system cancer	0.000134	0.00447	CcSEcCtD
Reserpine—Headache—Vincristine—lymphatic system cancer	0.000133	0.00445	CcSEcCtD
Reserpine—Nausea—Carmustine—lymphatic system cancer	0.000132	0.00442	CcSEcCtD
Reserpine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000132	0.0044	CcSEcCtD
Reserpine—Rash—Mitoxantrone—lymphatic system cancer	0.000131	0.00436	CcSEcCtD
Reserpine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000131	0.00435	CcSEcCtD
Reserpine—Headache—Mitoxantrone—lymphatic system cancer	0.00013	0.00433	CcSEcCtD
Reserpine—Nausea—Vincristine—lymphatic system cancer	0.000126	0.00422	CcSEcCtD
Reserpine—Nausea—Mitoxantrone—lymphatic system cancer	0.000123	0.00411	CcSEcCtD
Reserpine—Anorexia—Methotrexate—lymphatic system cancer	9.85e-05	0.00328	CcSEcCtD
Reserpine—Dyspnoea—Methotrexate—lymphatic system cancer	9.21e-05	0.00307	CcSEcCtD
Reserpine—Somnolence—Methotrexate—lymphatic system cancer	9.18e-05	0.00306	CcSEcCtD
Reserpine—Decreased appetite—Methotrexate—lymphatic system cancer	8.98e-05	0.00299	CcSEcCtD
Reserpine—Pain—Methotrexate—lymphatic system cancer	8.83e-05	0.00295	CcSEcCtD
Reserpine—Pruritus—Methotrexate—lymphatic system cancer	7.31e-05	0.00244	CcSEcCtD
Reserpine—Diarrhoea—Methotrexate—lymphatic system cancer	7.07e-05	0.00236	CcSEcCtD
Reserpine—Dizziness—Methotrexate—lymphatic system cancer	6.83e-05	0.00228	CcSEcCtD
Reserpine—Vomiting—Methotrexate—lymphatic system cancer	6.57e-05	0.00219	CcSEcCtD
Reserpine—Rash—Methotrexate—lymphatic system cancer	6.51e-05	0.00217	CcSEcCtD
Reserpine—Dermatitis—Methotrexate—lymphatic system cancer	6.51e-05	0.00217	CcSEcCtD
Reserpine—Headache—Methotrexate—lymphatic system cancer	6.47e-05	0.00216	CcSEcCtD
Reserpine—Nausea—Methotrexate—lymphatic system cancer	6.14e-05	0.00205	CcSEcCtD
